On Monday, Syra Health Corp (NASDAQ: SYRA) opened lower -4.46% from the last sessionbefore settling in for the closing price of $0.44. Price fluctuations for SYRA have ranged from $0.34 to $8.37 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 98.87%. Company’s average yearly earnings per share was noted -43.33% at the time writing. With a float of $3.44 million, this company’s outstanding shares have now reached $5.59 million.
Let’s determine the extent of company efficiency that accounts for 162 employees. In terms of profitability, gross margin is 11.34%, operating margin of -58.89%, and the pretax margin is -59.23%.
Syra Health Corp (SYRA) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Medical Care Facilities industry is another important factor to consider. The insider ownership of Syra Health Corp is 47.89%, while institutional ownership is 1.05%. The most recent insider transaction that took place on Dec 04 ’23, was worth 4,869. In this transaction CFO and COO of this company bought 4,271 shares at a rate of $1.14, taking the stock ownership to the 8,106 shares. Before that another transaction happened on Sep 29 ’23, when Company’s CFO and COO bought 918 for $3.30, making the entire transaction worth $3,029. This insider now owns 918 shares in total.
Syra Health Corp (SYRA) Recent Fiscal highlights
If we go through the results of last quarter, which was made public on 6/30/2024, the company posted -0.16 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -0.09) by -0.07. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.21 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -43.33% per share during the next fiscal year.
Syra Health Corp (NASDAQ: SYRA) Trading Performance Indicators
Check out the current performance indicators for Syra Health Corp (SYRA). In the past quarter, the stock posted a quick ratio of 3.14. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.39.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.67, a number that is poised to hit -0.21 in the next quarter
Technical Analysis of Syra Health Corp (SYRA)
Looking closely at Syra Health Corp (NASDAQ: SYRA), its last 5-days average volume was 1.2 million, which is a jump from its year-to-date volume of 0.92 million. As of the previous 9 days, the stock’s Stochastic %D was 11.97%. Additionally, its Average True Range was 0.13.
During the past 100 days, Syra Health Corp’s (SYRA) raw stochastic average was set at 3.99%, which indicates a significant decrease from 8.57% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 256.02% in the past 14 days, which was higher than the 160.10% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.1657, while its 200-day Moving Average is $1.3706. However, in the short run, Syra Health Corp’s stock first resistance to watch stands at $0.4469. Second resistance stands at $0.4734. The third major resistance level sits at $0.4869. If the price goes on to break the first support level at $0.4069, it is likely to go to the next support level at $0.3934. Now, if the price goes above the second support level, the third support stands at $0.3669.
Syra Health Corp (NASDAQ: SYRA) Key Stats
There are currently 6,422K shares outstanding in the company with a market cap of 2.77 million. Presently, the company’s annual sales total 5,520 K according to its annual income of -2,940 K. Last quarter, the company’s sales amounted to 1,970 K and its income totaled -1,390 K.
